🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 108 of 114

  1. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  2. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  3. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  4. gemcitabine and cisplatin; docetaxel, cisplatin and fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  5. gemcitabine,nimotuzumab, toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  6. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  7. gentamicin

    BRIGHT MINDS BIOSCIENCES INC.

    Plague

    phase 3 small molecule completed

    1 trial

  8. gilteritinib

    Astellas Pharma Inc

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule completed

    1 trial

  9. giroctocogene fitelparvovec

    Pfizer Australia Pty Ltd

    hemophilia A

    phase 3 small molecule active

    1 trial

  10. giroctocogene fitelparvovec, fidanacogene elaparvovec

    Pfizer Australia Pty Ltd

    hemophilia A, severe to moderately severe hemophilia B (FIX:C ≤ 2%)

    phase 3 small molecule active

    1 trial

  11. glutamine combined with thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mucositis Oral

    phase 3 small molecule completed

    1 trial

  12. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  13. granules for suspension, N-Acetyl-L-Leucine

    Intrabio Ireland Limited

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

  14. guanfacine

    Ultragenyx UK Limited

    Tourette Syndrome

    phase 3 small molecule completed

    1 trial

  15. human immunoglobulin G

    CSL Behring GmbH

    Dermatomyositis

    phase 3 small molecule terminated

    1 trial

  16. hydrocortisone (modified release), oral tablet 20 and 5 mg

    Takeda

    Adrenal Insufficiency

    phase 3 small molecule completed

    1 trial

  17. hydroxychloroquine (Z0188)

    Sanofi Pasteur

    Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

    phase 3 small molecule completed

    1 trial

  18. ianalumab

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  19. ianalumab s.c. q4w

    Novartis Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule active

    1 trial

  20. icatibant

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    2 trials

  21. idursulfase-IT

    Takeda

    Hunter Syndrome

    phase 3 mab active

    4 trials

  22. iloprost

    Ultragenyx UK Limited

    Systemic Sclerosis

    phase 3 small molecule completed

    1 trial

  23. immune globulin

    Ultragenyx UK Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  24. immune globulin

    Ultragenyx UK Limited

    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

    phase 3 small molecule completed

    2 trials

  25. individual lactation counseling and educational material

    Hospital Authority, Hong Kong

    Breastfeeding

    phase 3 other completed

    1 trial

  26. induced moderate hypothermia

    Hospital Authority, Hong Kong

    Traumatic Brain Injury

    phase 3 other terminated

    1 trial

  27. infigratinib 0.128 mg/kg/day

    BridgeBio Oncology Therapeutics

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  28. injectable naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  29. innohep® 10.000 anti Xa IU/0,5mL PF.SYR. Ενέσιμο διάλυμα, innohep® 18.000 anti Xa IU/0,9mL PF.SYR. Ενέσιμο διάλυμα, innohep® 14.000 anti Xa IU/0,7mL PF.SYR. Ενέσιμο διάλυμα

    The George Institute

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 small molecule active

    1 trial

  30. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 small molecule terminated

    1 trial

  31. insulin degludec

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    2 trials

  32. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  33. interferon alfa

    Ultragenyx UK Limited

    Hepatitis C

    phase 3 small molecule completed

    1 trial

  34. internal mammary nodal irradiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 3 other active

    1 trial

  35. iron isomaltoside(Monofer®)

    Hospital Authority, Hong Kong

    Anemia, Iron-Deficiency

    phase 3 small molecule completed

    1 trial

  36. lactose monohydrate - 100,00 mg/tablet cellulose microcrystalline - 95,60 mg/tablet Croscarmellose sodium - 2,00 mg/tablet Magnesium stearate - 2,40 mg/tablet table coating - OPADRY 20A82938 Yellow - COLORCON, Asmenol, 10 mg, tabletki powlekane

    COLLEGIUM PHARMACEUTICAL, INC

    Ischemia of the lower limbs in the course of obstructive artery disease

    phase 3 small molecule active

    1 trial

  37. lamotrigine, 300 mg/day

    GlaxoSmithKline

    Epilepsy, Partial

    phase 3 small molecule completed

    1 trial

  38. lapatinib

    GlaxoSmithKline

    Neoplasms, Breast

    phase 3 small molecule completed

    1 trial

  39. laser acupuncture

    Hospital Authority, Hong Kong

    Postpartum Weight Retention

    phase 3 other completed

    1 trial

  40. lasofoxifene

    LIGAND PHARMACEUTICALS INC

    Osteoporosis

    phase 3 small molecule completed

    3 trials

  41. lebrikizumab

    Hoffmann-La Roche

    Asthma

    phase 3 small molecule completed

    2 trials

  42. lefamulin

    Nabriva Therapeutics Ireland DAC

    Community Acquired Pneumonia

    phase 3 small molecule completed

    1 trial

  43. levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets

    Teva Pharma GmbH

    Dysmenorrhea

    phase 3 small molecule completed

    2 trials

  44. linaclotide

    Astellas Pharma Inc

    Chronic Constipation

    phase 3 small molecule completed

    1 trial

  45. linagliptine 5 mg

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  46. lipegfilgrastim

    Teva Pharma GmbH

    Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

    phase 3 small molecule completed

    1 trial

  47. liraglutide

    Novo Nordisk A/S

    Metabolism and Nutrition Disorder

    phase 3 small molecule completed

    1 trial

  48. liraglutide

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    2 trials

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.